-The Times of India Multinational stent companies claim that the ceiling price fixed by the National Pharmaceutical Pricing Authority (nppa) is commercially unviable, but they are selling at far lower prices in much richer countries with smaller markets than India such as Germany, the UK, Italy and many other European countries. A look at the prices of stent brands in these countries shows that people in India have been defrauded of crores...

-The Telegraph New Delhi: The government's price cap on coronary stents has not deterred the health-care industry from continuing to offer hospitals profit opportunities of tens of thousands of rupees on other kinds of stents, concerned doctors and health-care industry representatives said.     The National Pharmaceutical Pricing Authority (nppa), the government's price regulator, had on February 15 imposed a cap of about Rs 30,000 on coronary stents. But hospitals can continue to...

-The Times of India NEW DELHI: The government has invoked special powers under the law to prohibit stent makers from withdrawing their products from the market for the next six months. Amid reports that several manufacturers, including Abbott and Medtronic, are seeking to withdraw premium, high-priced stents from the Indian market on account of the price cap imposed by National Pharmaceutical Pricing Authority (nppa), the government has directed companies to maintain production,...

-The Times of India NEW DELHI: Promptly addressing complaints against hospitals that were allegedly overcharging for stents, the National Pharmaceutical Pricing Authority (nppa) has issued show-cause notices to Max Hospital, Saket (New Delhi), and Nidaan Hospital, Sonipat (Haryana). While the regulator said that the action is based on the findings of its preliminary investigation, both the hospitals denied the charge and maintained that they have "not overcharged a single patient" for stents. On...

-Down to Earth The average cost of drug eluting stent for domestic companies is around Rs 8,000 but it is sold to patients for Rs 24,000 to Rs 1.5 lakh In a decision that will benefit thousands of people in the country, the National Pharmaceutical Pricing Authority (nppa) has finally put a ceiling on prices of cardiac stent—a small mesh tube that's used to treat narrow or weak arteries. Cardiac stents...